Immune Therapeutics (OTCMKTS:IMUN – Get Free Report) and Vincerx Pharma (NASDAQ:VINC – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, earnings, institutional ownership, valuation, dividends and risk. Earnings & Valuation This table compares Immune […]
Immune Therapeutics (OTCMKTS:IMUN – Get Free Report) and Greenwich LifeSciences (NASDAQ:GLSI – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, risk, profitability, analyst recommendations and valuation. Insider & Institutional Ownership 4.9% of Greenwich […]
Immune Therapeutics, Inc. (OTCMKTS:IMUN – Get Free Report) saw a large increase in short interest in September. As of September 30th, there was short interest totalling 300 shares, an increase of 200.0% from the September 15th total of 100 shares. Based on an average trading volume of 21,100 shares, the days-to-cover ratio is currently 0.0 […]
Shares of Immune Therapeutics, Inc. (OTCMKTS:IMUN – Get Free Report) fell 3.2% during mid-day trading on Monday . The company traded as low as $0.26 and last traded at $0.29. 363 shares changed hands during mid-day trading, a decline of 98% from the average session volume of 15,492 shares. The stock had previously closed at […]
Shares of Immune Therapeutics, Inc. (OTCMKTS:IMUN – Get Free Report) dropped 2.9% during mid-day trading on Monday . The company traded as low as $0.85 and last traded at $0.85. Approximately 2,023 shares changed hands during trading, a decline of 58% from the average daily volume of 4,796 shares. The stock had previously closed at […]